{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:20:31Z","timestamp":1792376431773,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T00:00:00Z","timestamp":1306022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11033-011-0892-1","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T02:34:38Z","timestamp":1305945278000},"page":"1537-1540","source":"Crossref","is-referenced-by-count":17,"title":["Tumor necrosis factor alpha 308 G\/A polymorphism and Guillain-Barr\u00e9 syndrome risk"],"prefix":"10.1007","volume":"39","author":[{"given":"Hong","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiZhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuaBing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiHua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,22]]},"reference":[{"key":"892_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","volume":"100","author":"RA Hughes","year":"1999","unstructured":"Hughes RA, Hadden RD, Gregson NA et al (1999) Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 100:74\u201397","journal-title":"J Neuroimmunol"},{"key":"892_CR2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","volume":"56","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP et al (2001) Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56:758\u2013765","journal-title":"Neurology"},{"key":"892_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","volume":"39","author":"JW Griffin","year":"1996","unstructured":"Griffin JW, Li CY, Ho TW et al (1996) Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann Neurol 39:17\u201328","journal-title":"Ann Neurol"},{"key":"892_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.humimm.2010.06.013","volume":"71","author":"KN Prasad","year":"2010","unstructured":"Prasad KN, Nyati KK, Verma A et al (2010) Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barre syndrome. Hum Immunol 71:905\u2013910","journal-title":"Hum Immunol"},{"issue":"Pt 3","key":"892_CR5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"TW Ho","year":"1995","unstructured":"Ho TW, Mishu B, Li CY et al (1995) Guillain-Barre syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118(Pt 3):597\u2013605","journal-title":"Brain"},{"key":"892_CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2009.10.001","volume":"217","author":"S Huang","year":"2009","unstructured":"Huang S, Li L, Liang S et al (2009) Conversion of peripheral CD4(+)CD25(\u2212) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barre syndrome. J Neuroimmunol 217:80\u201384","journal-title":"J Neuroimmunol"},{"key":"892_CR7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","volume":"192","author":"LJ Chi","year":"2007","unstructured":"Chi LJ, Wang HB, Zhang Y et al (2007) Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barre syndrome. J Neuroimmunol 192:206\u2013214","journal-title":"J Neuroimmunol"},{"key":"892_CR8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coph.2004.04.004","volume":"4","author":"GM Anderson","year":"2004","unstructured":"Anderson GM, Nakada MT, DeWitte M (2004) Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4:314\u2013320","journal-title":"Curr Opin Pharmacol"},{"key":"892_CR9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q","volume":"50","author":"AH Hajeer","year":"2000","unstructured":"Hajeer AH, Hutchinson IV (2000) TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 50:216\u2013228","journal-title":"Microsc Res Tech"},{"key":"892_CR10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0198-8859(01)00322-6","volume":"62","author":"AH Hajeer","year":"2001","unstructured":"Hajeer AH, Hutchinson IV (2001) Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 62:1191\u20131199","journal-title":"Hum Immunol"},{"key":"892_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","volume":"1","author":"AG Wilson","year":"1992","unstructured":"Wilson AG, di Giovine FS, Blakemore AI et al (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353","journal-title":"Hum Mol Genet"},{"issue":"Suppl","key":"892_CR12","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 27(Suppl):S21\u2013S24","journal-title":"Ann Neurol"},{"key":"892_CR13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA et al (1998) Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 44:780\u2013788","journal-title":"Ann Neurol"},{"key":"892_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","volume":"58","author":"J Zhang","year":"2007","unstructured":"Zhang J, Dong H, Li B et al (2007) Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome. Eur Neurol 58:21\u201325","journal-title":"Eur Neurol"},{"key":"892_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0404.2009.01229.x","volume":"122","author":"S Sinha","year":"2010","unstructured":"Sinha S, Prasad KN, Jain D et al (2010) Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barre syndrome. Acta Neurol Scand 122:21\u201326","journal-title":"Acta Neurol Scand"},{"key":"892_CR16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2009.10.018","volume":"218","author":"KK Nyati","year":"2010","unstructured":"Nyati KK, Prasad KN, Verma A et al (2010) Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barre syndrome in Northern Indian population. J Neuroimmunol 218:116\u2013119","journal-title":"J Neuroimmunol"},{"key":"892_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2007.07.008","volume":"190","author":"K Geleijns","year":"2007","unstructured":"Geleijns K, Emonts M, Laman JD et al (2007) Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome. J Neuroimmunol 190:127\u2013130","journal-title":"J Neuroimmunol"},{"key":"892_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.01.016","volume":"162","author":"NM Sorge van","year":"2005","unstructured":"van Sorge NM, van der Pol WL, Jansen MD et al (2005) Severity of Guillain-Barre syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol 162:157\u2013164","journal-title":"J Neuroimmunol"},{"key":"892_CR19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(03)00133-4","volume":"139","author":"KM Myhr","year":"2003","unstructured":"Myhr KM, Vagnes KS, Maroy TH et al (2003) Interleukin-10 promoter polymorphisms in patients with Guillain-Barre syndrome. J Neuroimmunol 139:81\u201383","journal-title":"J Neuroimmunol"},{"key":"892_CR20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/thx.2005.051284","volume":"61","author":"J Gao","year":"2006","unstructured":"Gao J, Shan G, Sun B et al (2006) Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis. Thorax 61:466\u2013471","journal-title":"Thorax"},{"key":"892_CR21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.clinbiochem.2008.04.014","volume":"41","author":"N Li","year":"2008","unstructured":"Li N, Zhou Z, Liu X et al (2008) Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves\u2019 disease: a meta-analysis. Clin Biochem 41:881\u2013886","journal-title":"Clin Biochem"},{"key":"892_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000099159","volume":"57","author":"S Ristic","year":"2007","unstructured":"Ristic S, Lovrecic L, Starcevic-Cizmarevic N et al (2007) Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Eur Neurol 57:203\u2013207","journal-title":"Eur Neurol"},{"key":"892_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000070855","volume":"50","author":"J Drulovic","year":"2003","unstructured":"Drulovic J, Popadic D, Mesaros S et al (2003) Decreased frequency of the tumor necrosis factor alpha \u2212308 allele in Serbian patients with multiple sclerosis. Eur Neurol 50:25\u201329","journal-title":"Eur Neurol"},{"key":"892_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(92)90194-P","volume":"108","author":"HG Jenkins","year":"1992","unstructured":"Jenkins HG, Ikeda H (1992) Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J Neurol Sci 108:99\u2013104","journal-title":"J Neurol Sci"},{"issue":"Pt 4","key":"892_CR25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/brain\/118.4.869","volume":"118","author":"EJ Redford","year":"1995","unstructured":"Redford EJ, Hall SM, Smith KJ (1995) Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 118(Pt 4):869\u2013878","journal-title":"Brain"},{"key":"892_CR26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.410330606","volume":"33","author":"MK Sharief","year":"1993","unstructured":"Sharief MK, McLean B, Thompson EJ (1993) Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barre syndrome. Ann Neurol 33:591\u2013596","journal-title":"Ann Neurol"},{"key":"892_CR27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","volume":"34","author":"KM Kroeger","year":"1997","unstructured":"Kroeger KM, Carville KS, Abraham LJ (1997) The \u2212308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391\u2013399","journal-title":"Mol Immunol"},{"key":"892_CR28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jlb.66.4.562","volume":"66","author":"LJ Abraham","year":"1999","unstructured":"Abraham LJ, Kroeger KM (1999) Impact of the \u2212308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66:562\u2013566","journal-title":"J Leukoc Biol"},{"key":"892_CR29","first-page":"1101","volume":"98","author":"S Gonzalez","year":"2003","unstructured":"Gonzalez S, Rodrigo L, Martinez-Borra J et al (2003) TNF-alpha \u2212308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn\u2019s patients with fistulizing disease. Am J Gastroenterol 98:1101\u20131106","journal-title":"Am J Gastroenterol"},{"key":"892_CR30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1023\/B:CACO.0000036173.99930.75","volume":"15","author":"SY Ho","year":"2004","unstructured":"Ho SY, Wang YJ, Chen HL et al (2004) Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the \u2212308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15:657\u2013663","journal-title":"Cancer Causes Control"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-011-0892-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-011-0892-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-011-0892-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T21:30:36Z","timestamp":1560202236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-011-0892-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,22]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["892"],"URL":"https:\/\/doi.org\/10.1007\/s11033-011-0892-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,22]]}}}